Hycodan and Liver function tests nos abnormal - a phase IV clinical study of FDA data

Summary:

Liver function tests nos abnormal is found among people who take Hycodan, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Hycodan and have Liver function tests nos abnormal. It is created by eHealthMe based on reports of 684 people who have side effects when taking Hycodan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 24, 2023

684 people reported to have side effects when taking Hycodan.
Among them, 10 people (1.46%) have Liver function tests nos abnormal.

What is Hycodan?

Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 740 Hycodan users for its effectiveness, alternative drugs and more.

What is Liver function tests nos abnormal?

Liver function tests nos abnormal is found to be associated with 1,467 drugs and 170 conditions by eHealthMe.

Number of Hycodan and Liver function tests nos abnormal reports submitted per year:

Could Hycodan cause Liver function tests nos abnormal?

Gender of people who have Liver function tests nos abnormal when taking Hycodan *:

female: 40 %
male: 60 %

Age of people who have Liver function tests nos abnormal when taking Hycodan *:

Common drugs people take besides Hycodan *:

Common side effects people have besides Liver function tests nos abnormal *:

Blood Bilirubin Increased: 6 people, 60.00%
Asthma Aggravated: 3 people, 30.00%
Post-Operative Haemorrhage (post-operative bleeding): 3 people, 30.00%
Pneumonia Klebsiella (pneumonia caused by bacteria klebsiella): 3 people, 30.00%
Fever: 3 people, 30.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 30.00%
Haematocrit Decreased: 3 people, 30.00%
Haemoglobin Decreased: 3 people, 30.00%
Hypotension (abnormally low blood pressure): 3 people, 30.00%
Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hycodan and have Liver function tests nos abnormal?

Check whether Liver function tests nos abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Liver function tests nos abnormal and when was it recovered:

Liver function tests nos abnormal in Hycodan

Expand to all the drugs that have ingredients of homatropine methylbromide; hydrocodone bitartrate:

Liver function tests nos abnormal and drugs with ingredients of homatropine methylbromide; hydrocodone bitartrate (13 reports)

Alternative drugs to, pros and cons of Hycodan:

Hycodan (740 reports)

Common Hycodan side effects:

Cough: 102 reports

Browse all side effects of Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Liver function tests nos abnormal treatments and more:

Liver function tests nos abnormal (17,527 reports)

COVID vaccines that are related to Liver function tests nos abnormal:

Common drugs associated with Liver function tests nos abnormal:

All the drugs that are associated with Liver function tests nos abnormal:

Liver function tests nos abnormal (1,467 drugs)

All the conditions that are associated with Liver function tests nos abnormal:

Liver function tests nos abnormal (170 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate (the active ingredients of Hycodan) and Hycodan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.